SIOG research masterclass, helping to develop future researchers in geriatric oncology. Looking forward to this one. 19-21st March 2025 Paris #SIOG2024@SIOGorg@YoungSIOG
Cognitive issues in cancer patients are heterogeneous, not singular cause. The prevalence is high & means 1 in 5 to 1 in 10 cancer patients have impairments. How we address this is nuanced & needs informed discussions with patients. @meera_agar sheds light. #SIOG2024@SIOGorg
@meera_agar Palliative care needs differ between care givers & patients in symptom management & quality of life. Anticipating symptom development & planning is vital in neurooncology patient care. Place of care vs place of death are different & important. #SIOG2024@SIOGorg
Lack of inclusion of real world older patients in recent breast cancer trials. Non inferiority trials in older patients confound results when looking at deescalation treatment options in older patients. PROs and shorter trial designs are important. @EtienneB66#SIOG2024@SIOGorg
Patient preference in clinical treatments in cancer need to be individualised. This can be done in multiple ways and no one size fits all. @PierluigiBonomo#SIOG2024@SIOGorg
Frailty frameworks and working on different approaches to measure frailty with tools such as ELFI and Fried's frailty index. Use of https://t.co/GjqF0i5DyC can help guide the best tool to use. @KhengSoo1 summarises best approaches for gerionc clinical trials. @SIOGorg#SIOG2024
Fantastic talk by Penny Mackenzie highlighting models of radiation oncology and highlighting Australian data showing underutilisation of radiotherapy in older patients. #SIOG2024@SIOGorg@YoungSIOG
Thank you to the 2022-2024 @YoungSIOG Team for your tireless efforts! Inspiring! We celebrate all you have achieved together. Here is to continued success and collaboration. 👏 #SIOG2024#GeriOnc
Recovery starts before surgery, Incorporating Prehabilitation with Enhanced Recovery After Surgery pathways to improve outcomes in geriatric oncology surgery. Medically prescribed exercise and treat modifiable risk factors help #SIOG24@SIOGorg Francesco Carli
Frailty tools, useful in surgical evaluation. Clinical frailty scale and Edmonton frailty scales are well studied across multiple domains. Pragmatic and clinical impact of tools still needs to be better studied. @SIOGorg#SIOG2024 well presented Tyler Chesney
SIOG geriatrics special interest group bringing together great minds and ideas, towards advocating for better management for older patients with cancer. #SIOG2024@SIOGorg
Frailty index with the addition of L3 level CT generated myosteotosis or visceral adiposity both are predictive of frailty & poorer outcomes. This may provide a role for exercise in reversing sarcopenia in older cancer. @SIOGorg#SIOG2024@GrantWilliamsMD efthymios papadopoulos
@EnriqueSoto8 brilliant talk, implementing geriatric oncology in Mexico. Use of G8, Short physical performance battery and minicog when taught & performed by oncologists helps improve service delivery. Impact on clinical treatment relies on good communication. @SIOGorg#SIOG2024
Sentinel Lymph Node Biopsy vs No Axillary Procedure in Node-ve Breast Cancer. SLNB is just for staging and has worse patient reported outcomes. Early stage disease with favourable tumour biology may benefit from less intervention. @SIOGorg#siog2024 https://t.co/4AJXQsLwyB
Australian rad onc @lucindamorris23 highlighted advances in hypofractionation & use of SABR in oligometastases and primary disease positively impacts older patients with cancer both from curative & palliative perspectives. Referrals to rad onc need to improve. @SIOGorg#SIOG2024
Polypharmacy and potentially inappropriate prescribing cascades were highlighted in European geriatric medicine society meeting. Geriatrician input and clinical pharmacologists are vital in reviewing and screening #SIOG2024@SIOGorg@BBeauplet